Search

everythinglearnresearchcommunity

for

Search:↓

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Hair loss may indicate higher heart risk and metabolic issues.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.